
This study aimed to analyze NHS Digital data on kidney cancer patients in England from 2013 to 2019. The study examined the incidence, diagnosis routes, treatments, and survival trends. The data encompassed 66,696 individuals, with new diagnoses rising (8,998 in 2013 to 10,232 in 2019), but age-adjusted rates remained stable (18.7-19.4 per 100,000 population). Most patients were aged 0-70 years and often diagnosed at Stage 1-2. Diagnosis routes included general practitioner referrals, two-week wait, and emergencies. Treatment approaches varied based on disease stage, patient factors, and treatment network. Survival outcomes differed by stage, subtype, and socioeconomic status. Despite changes in treatment, survival rates remained constant, while potential immunotherapy effects were not covered. The study's insights aid the forthcoming National Kidney Cancer Audit and caution about diagnosis routes' limitations and stable survival rates.
Like
Save
Share